Biocon Biologics, a wholly-owned subsidiary of Biocon, received marketing approval for its pegfilgrastim biosimilar (Product) from Japan's Ministry of Health, Labour and Welfare (MHLW).
Market Samachar is a news aggregator. This article was originally published by Share Market Today. Tap the button above to read the full story on their site.